Chiasma Reports First Quarter 2017 Results
05 mai 2017 08h00 HE
|
Chiasma, Inc.
WALTHAM, Mass., May 05, 2017 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ:CHMA), a clinical-stage biopharmaceutical company focused on improving the lives of patients with rare and serious chronic...